Consolidated Statements of Shareholders' Equity - USD ($) $ in Thousands	Total	Common stock	Additional paid-in capital	Treasury stock	Retained earnings	Accumulated other comprehensive loss
Beginning of period (in shares) at Oct. 01, 2022		27,679,000
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)		209,000
Treasury shares purchased (in shares)		(241,000)
End of period (in shares) at Apr. 01, 2023		27,647,000
Beginning of period at Oct. 01, 2022	$ 1,095,731	$ 541	$ 652,467	$ (1,093,483)	$ 1,572,234	$ (36,028)
Exercise of stock options and vesting of other share-based awards		2
Share-based compensation expense			11,482
Exercise of stock options and vesting of other share-based awards, including tax withholding			(12,282)
Treasury shares purchased				(23,877)
Net income	83,034				83,034
Other comprehensive (loss) income	28,292					28,292
End of period at Apr. 01, 2023	1,182,382	$ 543	651,667	(1,117,360)	1,655,268	(7,736)
Beginning of period (in shares) at Dec. 31, 2022		27,612,000
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)		160,000
Treasury shares purchased (in shares)		(125,000)
End of period (in shares) at Apr. 01, 2023		27,647,000
Beginning of period at Dec. 31, 2022	1,150,259	$ 541	654,059	(1,104,953)	1,614,424	(13,812)
Exercise of stock options and vesting of other share-based awards		2
Share-based compensation expense			5,799
Exercise of stock options and vesting of other share-based awards, including tax withholding			(8,191)
Treasury shares purchased				(12,407)
Net income	40,844				40,844
Other comprehensive (loss) income	6,076					6,076
End of period at Apr. 01, 2023	$ 1,182,382	$ 543	651,667	(1,117,360)	1,655,268	(7,736)
Beginning of period (in shares) at Sep. 30, 2023	27,466,000	27,466,000
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)		190,000
Treasury shares purchased (in shares)		(186,000)
End of period (in shares) at Mar. 30, 2024	27,470,000	27,470,000
Beginning of period at Sep. 30, 2023	$ 1,214,382	$ 543	661,270	(1,134,429)	1,711,328	(24,330)
Exercise of stock options and vesting of other share-based awards		2
Share-based compensation expense			12,685
Exercise of stock options and vesting of other share-based awards, including tax withholding			(10,825)
Treasury shares purchased				(17,568)
Net income	45,454				45,454
Other comprehensive (loss) income	15,632					15,632
End of period at Mar. 30, 2024	$ 1,259,762	$ 545	663,130	(1,151,997)	1,756,782	(8,698)
Beginning of period (in shares) at Dec. 30, 2023		27,504,000
Stock issued during period, stock options exercised and vesting of other stock awards (in shares)		152,000
Treasury shares purchased (in shares)		(186,000)
End of period (in shares) at Mar. 30, 2024	27,470,000	27,470,000
Beginning of period at Dec. 30, 2023	$ 1,266,755	$ 543	663,542	(1,134,429)	1,740,543	(3,444)
Exercise of stock options and vesting of other share-based awards		2
Share-based compensation expense			7,506
Exercise of stock options and vesting of other share-based awards, including tax withholding			(7,918)
Treasury shares purchased				(17,568)
Net income	16,239				16,239
Other comprehensive (loss) income	(5,254)					(5,254)
End of period at Mar. 30, 2024	$ 1,259,762	$ 545	$ 663,130	$ (1,151,997)	$ 1,756,782	$ (8,698)